Cost of sustained release treatment of CMV retinitis.
Weitzner
A
A
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000191:economics; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy / Q000191:economics*; D003692:Delayed-Action Preparations; D016503:Drug Delivery Systems; D015774:Ganciclovir / Q000191:economics* / Q000627:therapeutic use; D006801:Humans
D003692:Delayed-Action Preparations; D015774:Ganciclovir